Cutaneous Rosai-Dorfman Disease: A Case Report

Main Article Content

Nahla Shihab
Whitney Talbott
Nathalie O Kahn
Erisa Alia
Jeffrey M Weinberg

Keywords

Cutaneous Rosai-Dorfman disease, Rosai Dorfman disease, histiocytosis

Abstract

Cutaneous Rosai-Dorfman Disease (CRDD) is an uncommon benign histiocytosis of unknown etiology. CRDD is oftentimes misdiagnosed because it has variable clinical manifestations, particularly in the absence of lymphadenopathy. We report a case of a 23-year-old African American woman presenting with clustered nodular plaques on her right thigh, buttocks, back, and chest for the past two years. History, clinical, histopathological, and immunochemistry findings corresponded with CRDD, and as such, she was treated with halobetasol propionate 0.05% cream twice daily.

References

Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, Fletcher CDM, et al. Cutaneous Rosai-Dorfman disease is a distinct clinical entity. Am J Dermatopathol. 2002;24(5):385-91.

Wang K-H, Chen W-Y, Liu H-N, Huang C-C, Lee W-R, Hu C-H. Cutaneous Rosai–Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients. Br J Dermatol. 2006;154:277-86.

Rubenstein MA, Farnsworth NN, Pielop JA, Orengo IF, Curry JL, Drucker CR, et al. Cutaneous Rosai-Dorfman disease. Dermatol Online J. 2006;12(1):8.

Farooq U, Chacon AH, VIncek V, Elgart GW. Purely cutaneous Rosai-Dorfman disease with immunohistochemistry. Indian J Dermatol. 2013;58(6):447-52.

Hinojosa T, Ramos E, Lewis DJ, Angel Ld, Vangipuram R, Peranteau AJ, et al. Cutaneous Rosai-Dorfman disease: A separate clinical entity. J Dermatol & Dermatol Surg. 2017;21:107-9.

Jia J, Tian Q, Zhang H, Zheng Y. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body. Int J Dermatol. 2017;56:576-8.

Kinio AE, Sawchuk MA, Pratt M. Atypical primary cutaneous Rosai-Dorfman disease: A case report. J Cutan Med Surg. 2017;21(5):460-3.

Khoo JJ, Othman Rb. Cutaneous Rosai-Dorfman disease. Malaysian J Pathol. 2007;29(1):49-52.

Middel P, Hemmerlein B, Fayyazi A, Kaboth U, Radzun HJ. Sinus histiocytosis with massive lymphadenopathy: Evidence for its relationship to macrophages and for a cytokine-related disorder. Histopathology. 1999;35:525-33.

Landim FM, Rios HdO, Costa CO, Feitosa RGF, Costa AAA. Cutaneous Rosai-Dorfman disease. An Bras Dermatol. 2009;84(3):1-5.

Salim A, Williamson M, Barker F, Hughes J. Steroid responsive cutaneous Rosai–Dorfman disease associated with uveitis and hypothyroidism. Clin Exp Dermatol. 2002;27:277-9.

Kong Y, Kong J, Shi D, Lu H, Zhu X, Wang J. Cutaneous Rosai-Dorfman disease a clinical and histopathologic study of 25 cases in China. Am J Surg Pathol. 2007;31:341-50.

Lu C-I, Kuo T-t, Wong W-R, Hong H-S. Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan. J Am Acad Dermatol. 2004;51:931-9.

Scheel MM, Rady PL, Tyring SK, Pandya AG. Sinus histiocytosis with massive lymphadenopathy: Presentation as giant granuloma annulare and detection of human herpesvirus 6. J Am Acad Dermatol. 1997;37:643-6.

Annesi G, Giannetti A. Purely cutaneous Rosai-Dorfman disease. Br J Dermatol. 1996;134:749-53.

Lai FM-M, Lam WY, Chin CW, Ng WL. Cutaneous Rosai-Dorfman disease presenting as a suspicious breast mass. J Cutan Pathol. 1994;21:377-82.

Article Sidebar

Full Article PDF
Published
Jul 6, 2018
DOI https://doi.org/10.25251/skin.2.4.7

Article Details

How to Cite
Shihab, N., Talbott, W., Kahn, N. O., Alia, E., & Weinberg, J. M. (2018). Cutaneous Rosai-Dorfman Disease: A Case Report. SKIN The Journal of Cutaneous Medicine, 2(4), 243–247. https://doi.org/10.25251/skin.2.4.7
Issue
Vol. 2 No. 4 (2018)
Section
Brief Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.